| IL-28, IL-29 and their class II cytokine receptor IL-28R P Sheppard, W Kindsvogel, W Xu, K Henderson, S Schlutsmeyer, ... Nature immunology 4 (1), 63-68, 2003 | 2114 | 2003 |
| TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease JA Gross, J Johnston, S Mudri, R Enselman, SR Dillon, K Madden, W Xu, ... Nature 404 (6781), 995-999, 2000 | 1491 | 2000 |
| Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival AJ Novak, JR Darce, BK Arendt, B Harder, K Henderson, W Kindsvogel, ... Blood 103 (2), 689-694, 2004 | 684 | 2004 |
| Expression cloning and signaling properties of the rat glucagon receptor LJ Jelinek, S Lok, GB Rosenberg, RA Smith, FJ Grant, S Biggs, ... Science 259 (5101), 1614-1616, 1993 | 488 | 1993 |
| A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist W Xu, SR Presnell, J Parrish-Novak, W Kindsvogel, S Jaspers, Z Chen, ... Proceedings of the National Academy of Sciences 98 (17), 9511-9516, 2001 | 278 | 2001 |
| A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus J Hager, L Hansen, C Vaisse, N Vionnet, A Philippi, W Poller, G Velho, ... Nature genetics 9 (3), 299-304, 1995 | 235 | 1995 |
| The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization S Lok, JL Kuijper, LJ Jelinek, JM Kramer, TE Whitmore, CA Sprecher, ... Gene 140 (2), 203-209, 1994 | 157 | 1994 |
| Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo. GA Wayman, S Impey, Z Wu, W Kindsvogel, L Prichard, DR Storm Journal of Biological Chemistry 269 (41), 25400-25405, 1994 | 150 | 1994 |
| Method of producing secreted receptor analogs and biologically active peptide dimers AZ Sledziewski, LA Bell, WR Kindsvogel US Patent 5,155,027, 1992 | 136 | 1992 |
| Ligand-binding, dimerized polypeptide fusions AZ Sledziewski, LA Bell, WR Kindsvogel US Patent 6,323,323, 2001 | 135 | 2001 |
| IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic … A Gowda, J Roda, SRA Hussain, A Ramanunni, T Joshi, S Schmidt, ... Blood, The Journal of the American Society of Hematology 111 (9), 4723-4730, 2008 | 124 | 2008 |
| Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions AZ Sledziewski, LA Bell, WR Kindsvogel US Patent 5,843,725, 1998 | 118 | 1998 |
| Dimerized polypeptide fusions AZ Sledziewski, LA Bell, WR Kindsvogel US Patent 6,291,646, 2001 | 96 | 2001 |
| An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal … J Hu, W Kindsvogel, S Busby, MC Bailey, YY Shi, PD Greenberg The Journal of experimental medicine 177 (6), 1681-1690, 1993 | 94 | 1993 |
| Methods for producing secreted ligand-binding fusion proteins AZ Sledziewski, LA Bell, WR Kindsvogel US Patent 6,300,099, 2001 | 88 | 2001 |
| DNA constructs encoding ligand-binding fusion proteins AZ Sledziewski, LA Bell, WR Kindsvogel US Patent 6,291,212, 2001 | 88 | 2001 |
| Biologically active dimerized and multimerized polypeptide fusions AZ Sledziewski, LA Bell, WR Kindsvogel US Patent 6,018,026, 2000 | 88 | 2000 |
| Methods for treating viral infection using IL-28 and IL-29 KM Klucher, PV Sivakumar, WR Kindsvogel, KE Henderson US Patent 7,135,170, 2006 | 86 | 2006 |
| Cytokine protein family PO Sheppard, BA Fox, KM Klucher, DW Taft, W Kindsvogel US Patent 7,038,032, 2006 | 84 | 2006 |
| Human cytokine receptor SR Presnell, W Xu, W Kindsvogel, Z Chen US Patent 6,897,292, 2005 | 80 | 2005 |
